These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 32650208)

  • 41. Association of nosocomial infections with delayed cerebral ischemia in aneurysmal subarachnoid hemorrhage.
    Foreman PM; Chua M; Harrigan MR; Fisher WS; Vyas NA; Lipsky RH; Walters BC; Tubbs RS; Shoja MM; Griessenauer CJ
    J Neurosurg; 2016 Dec; 125(6):1383-1389. PubMed ID: 26871202
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Safety and Efficacy of 1-Month Dual Antiplatelet Therapy (Ticagrelor + Aspirin) Followed by 23-Month Ticagrelor Monotherapy in Patients Undergoing Staged Percutaneous Coronary Intervention (A Sub-Study from GLOBAL LEADERS).
    Kawashima H; Tomaniak M; Ono M; Wang R; Hara H; Gao C; Takahashi K; Sharif F; Thury A; Suryapranata H; Walsh S; Cotton J; Carrie D; Sabate M; Steinwender C; Leibundgut G; Wykrzykowska J; de Winter RJ; Garg S; Hamm C; Steg PG; Jüni P; Vranckx P; Valgimigli M; Windecker S; Onuma Y; Serruys PW
    Am J Cardiol; 2021 Jan; 138():1-10. PubMed ID: 33065080
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Significance of fluctuations in serum sodium levels following aneurysmal subarachnoid hemorrhage: an exploratory analysis.
    Eagles ME; Tso MK; Macdonald RL
    J Neurosurg; 2019 Aug; 131(2):420-425. PubMed ID: 30117765
    [TBL] [Abstract][Full Text] [Related]  

  • 44. An overview of pharmacotherapy for cerebral vasospasm and delayed cerebral ischemia after subarachnoid hemorrhage.
    Maruhashi T; Higashi Y
    Expert Opin Pharmacother; 2021 Aug; 22(12):1601-1614. PubMed ID: 33823726
    [No Abstract]   [Full Text] [Related]  

  • 45. Ultra-Early Angiographic Vasospasm After Aneurysmal Subarachnoid Hemorrhage: A Systematic Review and Meta-Analysis.
    Phan K; Moore JM; Griessenauer CJ; Xu J; Teng I; Dmytriw AA; Chiu AH; Ogilvy CS; Thomas A
    World Neurosurg; 2017 Jun; 102():632-638.e1. PubMed ID: 28365434
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Detection of delayed cerebral ischemia using objective pupillometry in patients with aneurysmal subarachnoid hemorrhage.
    Aoun SG; Stutzman SE; Vo PN; El Ahmadieh TY; Osman M; Neeley O; Plitt A; Caruso JP; Aiyagari V; Atem F; Welch BG; White JA; Batjer HH; Olson DM
    J Neurosurg; 2020 Jan; 132(1):27-32. PubMed ID: 30641848
    [TBL] [Abstract][Full Text] [Related]  

  • 47. P2Y12 inhibitor monotherapy versus aspirin monotherapy after short-term dual antiplatelet therapy for percutaneous coronary intervention: Insights from a network meta-analysis of randomized trials.
    Kuno T; Ueyama H; Takagi H; Bangalore S
    Am Heart J; 2020 Sep; 227():82-90. PubMed ID: 32693196
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Prospective observational cohort study of the association between antiplatelet therapy, bleeding and thrombosis in patients with coronary stents undergoing noncardiac surgery.
    Howell SJ; Hoeks SE; West RM; Wheatcroft SB; Hoeft A;
    Br J Anaesth; 2019 Feb; 122(2):170-179. PubMed ID: 30686302
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Neuroprotective effect of dapsone in patients with aneurysmal subarachnoid hemorrhage: a prospective, randomized, double-blind, placebo-controlled clinical trial.
    García-Pastor C; Navarro-Garcia de Llano JP; Balcázar-Padrón JC; Tristán-López L; Rios C; Díaz-Ruíz A; Rodríguez-Hernandez LA; Nathal E
    Neurosurg Focus; 2022 Mar; 52(3):E12. PubMed ID: 35231887
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Antiplatelet therapy for the prevention of peri-coiling thromboembolism in high-risk patients with ruptured intracranial aneurysms.
    Edwards NJ; Jones WH; Sanzgiri A; Corona J; Dannenbaum M; Chen PR
    J Neurosurg; 2017 Dec; 127(6):1326-1332. PubMed ID: 28059659
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Antiplatelet Therapy in Patients with Aneurysmal SAH: Impact on Delayed Cerebral Ischemia and Clinical Outcome. A Meta-Analysis.
    Cagnazzo F; Derraz I; Lefevre PH; Gascou G; Dargazanli C; Riquelme C; Perrini P; di Carlo D; Bonafe A; Costalat V
    AJNR Am J Neuroradiol; 2019 Jul; 40(7):1201-1206. PubMed ID: 31171518
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effect of P2Y12 Inhibitor Monotherapy vs Dual Antiplatelet Therapy on Cardiovascular Events in Patients Undergoing Percutaneous Coronary Intervention: The SMART-CHOICE Randomized Clinical Trial.
    Hahn JY; Song YB; Oh JH; Chun WJ; Park YH; Jang WJ; Im ES; Jeong JO; Cho BR; Oh SK; Yun KH; Cho DK; Lee JY; Koh YY; Bae JW; Choi JW; Lee WS; Yoon HJ; Lee SU; Cho JH; Choi WG; Rha SW; Lee JM; Park TK; Yang JH; Choi JH; Choi SH; Lee SH; Gwon HC;
    JAMA; 2019 Jun; 321(24):2428-2437. PubMed ID: 31237645
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Rebleeding drives poor outcome in aneurysmal subarachnoid hemorrhage independent of delayed cerebral ischemia: a propensity-score matched cohort study.
    Lu VM; Graffeo CS; Perry A; Carlstrom LP; Rangel-Castilla L; Lanzino G; Brinjikji W; Wijdicks EFM; Rabinstein AA
    J Neurosurg; 2020 Aug; 133(2):360-368. PubMed ID: 31323638
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effect of statin treatment on vasospasm-related morbidity and functional outcome in patients with aneurysmal subarachnoid hemorrhage: a systematic review and meta-analysis.
    Shen J; Huang KY; Zhu Y; Pan JW; Jiang H; Weng YX; Zhan RY
    J Neurosurg; 2017 Aug; 127(2):291-301. PubMed ID: 27715439
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The p48 Flow Modulation Device with Hydrophilic Polymer Coating (HPC) for the Treatment of Acutely Ruptured Aneurysms: Early Clinical Experience Using Single Antiplatelet Therapy.
    Aguilar-Perez M; Hellstern V; AlMatter M; Wendl C; Bäzner H; Ganslandt O; Henkes H
    Cardiovasc Intervent Radiol; 2020 May; 43(5):740-748. PubMed ID: 32030488
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effect of Premorbid Antiplatelet Medication Use on Delayed Cerebral Ischemia After Aneurysmal Subarachnoid Hemorrhage: A Propensity Score-matched Study.
    Enriquez-Marulanda A; Salem MM; Ravindran K; Ascanio LC; Maragkos GA; Gomez-Paz S; Alturki AY; Ogilvy CS; Thomas AJ; Moore J
    Cureus; 2019 Sep; 11(9):e5603. PubMed ID: 31700716
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Dual antiplatelet therapy using cilostazol for secondary prevention in patients with high-risk ischaemic stroke in Japan: a multicentre, open-label, randomised controlled trial.
    Toyoda K; Uchiyama S; Yamaguchi T; Easton JD; Kimura K; Hoshino H; Sakai N; Okada Y; Tanaka K; Origasa H; Naritomi H; Houkin K; Yamaguchi K; Isobe M; Minematsu K;
    Lancet Neurol; 2019 Jun; 18(6):539-548. PubMed ID: 31122494
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Dual antiplatelet therapy is associated with prolonged survival after lower extremity revascularization.
    Soden PA; Zettervall SL; Ultee KH; Landon BE; O'Malley AJ; Goodney PP; DeMartino RR; Arya S; Schermerhorn ML;
    J Vasc Surg; 2016 Dec; 64(6):1633-1644.e1. PubMed ID: 27575814
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Benefits and Risks of Prolonged Duration Dual Antiplatelet Therapy (Clopidogrel and Aspirin) After Percutaneous Coronary Intervention in High-Risk Patients With Diabetes Mellitus.
    Wang HY; Cai ZX; Yin D; Yang YJ; Song WH; Dou KF
    Am J Cardiol; 2021 Mar; 142():14-24. PubMed ID: 33285091
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cervical spinal cord stimulation for prevention and treatment of cerebral vasospasm after aneurysmal subarachnoid hemorrhage: clinical and radiographic outcomes of a prospective single-center clinical pilot study.
    Slavin KV; Vannemreddy P
    Acta Neurochir (Wien); 2022 Nov; 164(11):2927-2937. PubMed ID: 35920945
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.